Good news for people newly diagnosed with MOGAD: Study finds low relapse risk
People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente study. Researchers from Kaiser Permanente in Southern California followed 69 children and adults diagnosed ...
Featured News
Ultraprocessed foods linked to body fat gain in children
Children who ate more ultraprocessed foods showed stronger activity in a part of the brain involved in reward, and that brain response was linked to greater gains in body fat over the following year, ...
No increased stroke risk found after COVID-19 and flu vaccinations
A large multisite study found that bivalent mRNA COVID-19 vaccination, flu vaccination, and same-day administration of both vaccines were not associated with an increased risk of first-ever ischemic ...
RSV vaccine protects older adults for at least 3 seasons
An RSV vaccine continued to protect adults aged 60 and older against RSV-related hospitalization and emergency department visits for at least 3 seasons after vaccination, according to a new study by ...
Education-focused diabetes care linked to better blood sugar control
May 4, 2026A large study conducted within Kaiser Permanente Southern California found that people with type 2 diabetes who primarily received diabetes self-management education and support were more likely to achieve healthy blood sugar levels than those whose care focused mainly on physician visits. “For people living with type 2 diabetes, this study shows that actively participating in ...Read more...Nurses in research: Beatriz Alviso advances patient-centered science
May 4, 2026This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Beatriz Alviso, RN, PHN, BSN who works in the Division of Health Services Research & Implementation Science. What is your background? I grew up rollerblading in ...Read more...Nurses in research: Christina Flores builds trust and understanding in vaccine studies
May 4, 2026This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Christina Flores, LVN, who works in vaccine and infectious disease clinical trials. What is your background? I grew up in Highland Park, California, and began my ...Read more...Nurses in research: Sarah Ruiz supports pediatric patients through clinical trials
May 4, 2026This week, Nurses Week (May 6-12, 2026), we honor all the nurses who work within the Department of Research & Evaluation, who are a vital part of our research. Here we highlight Sarah Ruiz, BSN, RN, PHN, who works in bone marrow transplant and pediatric clinical trials. What is your background? I grew up in Texas, primarily the ...Read more...When more isn’t more: Smaller restaurant portions left diners just as full
April 28, 2026Restaurants in the United States are known for generous portions, often serving far more food than most adults need in a single meal. Those oversized portions have long been linked to overeating and, over time, to higher rates of obesity and chronic disease. A new study conducted in real restaurants suggests there may be a ...Read more...Transforming sight through clinical trials
April 22, 2026While the typical assumption would be that it takes a major academic campus to foster medical innovation, Kaiser Permanente is proving that wrong. The Kaiser Permanente Riverside Medical Center has become a hub for clinical trial innovation under the direction of Vivienne Hau, MD, PhD, a medical and surgical vitreoretinal specialist who has built a retinal ...Read more...Managing blood pressure may change breast cancer outlook
March 11, 2026A new Kaiser Permanente study suggests that managing high blood pressure may help women with advanced breast cancer live longer. The study found that women who took more than one type of blood pressure drug were much less likely to die than those taking just one type.Read more...5 questions for Dr. Hui Zhou
February 19, 2026Hui Zhou PhD, MS, is the biostatistician lead in the Division of Epidemiologic Research for the Department of Research & Evaluation. There she collaborates with epidemiologists and clinical investigators on research studies ranging from conditions like hypertension, diabetes, chronic kidney disease, cardiovascular disease, and bone fractures. Dr. Zhou has extensive research experience in prediction model ...Read more...Study evaluates heart disease risk prediction across Asian ethnicities
February 19, 2026A Kaiser Permanente study found that the PREVENT cardiovascular risk equation had strong overall ability to predict 10-year cardiovascular disease risk in Asian, Native Hawaiian, and Other Pacific Islander adults. However, its accuracy differed across specific Asian ethnic subgroups and showed consistent patterns of over- and under-estimating when grouping by race and ethnicity. The study went ...Read more...Rethinking MS treatment: Why less may be more
February 3, 2026For years, people living with relapsing forms of multiple sclerosis (MS) have depended on powerful medications to keep their disease under control. One of the most effective treatments has been rituximab, a therapy that works by depleting B cells, which are the immune cells that drive inflammation with MS. However, new research from Kaiser Permanente Southern ...Read more...